Delivery Order SPE2DB20D3304-SPE2DB25FW4M9

Award Date 11/13/24
Potential Completion Date 12/5/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,416.00, is for the procurement of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, which are likely COVID-19 vaccine syringes. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,083.05, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes. This is a firm fixed-price delivery order contract with a completion date of November 19, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX 2024-25 (12Y UP) syringes (0.5ML) with a ceiling value of $2,863.56. The contract is a firm fixed price delivery order, with an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,885.75, is for the delivery of SPIKEVAX 2023-24 (12Y UP) syringes, 0.5ML, with a completion date of February 6, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,357.70, is for the delivery of SPIKEVAX 2023-24 (12Y UP) SYRG 0.5ML syringes. The award has an ultimate completion date of December 19, 2023, and is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,367.93 firm fixed-price delivery order is for SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, with a completion date of September 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,334.68 firm-fixed-price delivery order is for the supply of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML vaccines, with an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,147.64, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML vaccines, with a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,863.56 firm fixed-price delivery order is for the procurement of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes, with a period of performance through December 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,418.00 contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) syringes, 0.5 ml, to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW4M9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes. The order, valued at $2,836.00, has a firm fixed-price contract type and an ultimate completion date of December 5, 2024. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition. The contract award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 2/12/25, 9:32 AM